<qa>  What is the time frame for the HbA1c study?Study Design and Description The study is designed to run for a period of 3 months of intensive management for each enrolled patient as they begin insulin pump therapy plus detailed glucose records beginning 4 weeks prior to the initiation of insulin pump therapy. Understanding relative glucose control following intensive management requires that we consider the results of the patients HbA1c 3 months after conclusion of intensive management thus extending the time frame to 6 months. 